Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients
Stanic, Karmen, Turnsek, Nina, Vrankar, Martina
Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study
Turnsek, Nina, Devjak, Rok, Edelbaher, Natalija, Osrajnik, Ilonka, Unk, Mojca, Vidovic, Dusanka, Jeric, Tina, Janzic, Urska